相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone
Teijo I. Saari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain
Volker Huge et al.
EUROPEAN JOURNAL OF PAIN (2010)
Use of oral ketamine in chronic pain management: A review
Maren I. Blonk et al.
EUROPEAN JOURNAL OF PAIN (2010)
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine
Nora M. Hagelberg et al.
EUROPEAN JOURNAL OF PAIN (2010)
Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
Simone Portmann et al.
JOURNAL OF CHROMATOGRAPHY A (2010)
Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain Preliminary Findings from a Three-Way Randomized, Crossover Study
Chui Chong et al.
CLINICAL DRUG INVESTIGATION (2009)
Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes
Marta Kot et al.
PHARMACOLOGICAL REPORTS (2009)
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M. Zanger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Inhibition and induction of human cytochrome P450 enzymes: current status
Olavi Pelkonen et al.
ARCHIVES OF TOXICOLOGY (2008)
The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals
Yasmine Nivoix et al.
CLINICAL PHARMACOKINETICS (2008)
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP)
Anshul Gupta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Polymorphic CYP2B6:: molecular mechanisms and emerging clinical significance
Ulrich M. Zanger et al.
PHARMACOGENOMICS (2007)
Effect of itraconazole on pharmacokinetics of paroxetine: The role of gut transporters
Norio Yasui-Furukori et al.
THERAPEUTIC DRUG MONITORING (2007)
Evaluation of 227 drugs for in vitro inhibition of cytochrome P4502B6
Robert L. Walsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The functional role of CYP2B6 in human drug metabolism:: Substrates and inhibitors in vitro, in vivo and in silico
Miia Turpeinen et al.
CURRENT DRUG METABOLISM (2006)
The role of ketamine in pain management
E. Visser et al.
BIOMEDICINE & PHARMACOTHERAPY (2006)
Effect of clopidogrel and ticlopidine on cytochrome P4502B6 activity as measured by bupropion hydroxylation
M Turpeinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history
E Michna et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine
T Richter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes
Y Hijazi et al.
DRUG METABOLISM AND DISPOSITION (2002)
Interaction of common azole antifungals with P glycoprotein
EJ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P4502C19
NT Ha-Duong et al.
BIOCHEMISTRY (2001)
Targeting the N-methyl-D-aspartate receptor for chronic pain management:: Preclinical animal studies, recent clinical experience and future research directions
K Fisher et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
